Xialin Zuo

1.1k total citations
20 papers, 799 citations indexed

About

Xialin Zuo is a scholar working on Molecular Biology, Neurology and Cancer Research. According to data from OpenAlex, Xialin Zuo has authored 20 papers receiving a total of 799 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Neurology and 6 papers in Cancer Research. Recurrent topics in Xialin Zuo's work include Neuroinflammation and Neurodegeneration Mechanisms (7 papers), Alzheimer's disease research and treatments (4 papers) and Circular RNAs in diseases (4 papers). Xialin Zuo is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (7 papers), Alzheimer's disease research and treatments (4 papers) and Circular RNAs in diseases (4 papers). Xialin Zuo collaborates with scholars based in China, Hong Kong and Norway. Xialin Zuo's co-authors include Aimin Ji, Houliang Deng, Ping Wu, Xiaoxia Liu, Li Liu, Qian Xu, Zhuomin Wu, Xiaoxia Liu, Li Liu and Shuai He and has published in prestigious journals such as Nucleic Acids Research, Antioxidants and Redox Signaling and Neuropharmacology.

In The Last Decade

Xialin Zuo

20 papers receiving 789 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xialin Zuo China 13 561 432 91 67 64 20 799
Zhaoji Liu China 13 372 0.7× 230 0.5× 87 1.0× 110 1.6× 39 0.6× 15 680
Reiner Kunze Germany 18 357 0.6× 261 0.6× 222 2.4× 87 1.3× 106 1.7× 27 773
Jianhua Su China 12 282 0.5× 181 0.4× 55 0.6× 36 0.5× 63 1.0× 32 536
Camille A. Juźwik Canada 8 345 0.6× 245 0.6× 101 1.1× 23 0.3× 88 1.4× 9 628
Zhengli Di China 11 346 0.6× 190 0.4× 94 1.0× 62 0.9× 37 0.6× 22 549
Jianbo Feng China 16 472 0.8× 309 0.7× 45 0.5× 66 1.0× 113 1.8× 28 768
Ningbo Xu China 20 642 1.1× 391 0.9× 186 2.0× 120 1.8× 97 1.5× 33 1.1k
Jeff W. Hill United States 10 381 0.7× 134 0.3× 135 1.5× 63 0.9× 45 0.7× 13 588
Ai Chen China 11 331 0.6× 147 0.3× 29 0.3× 79 1.2× 74 1.2× 20 571

Countries citing papers authored by Xialin Zuo

Since Specialization
Citations

This map shows the geographic impact of Xialin Zuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xialin Zuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xialin Zuo more than expected).

Fields of papers citing papers by Xialin Zuo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xialin Zuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xialin Zuo. The network helps show where Xialin Zuo may publish in the future.

Co-authorship network of co-authors of Xialin Zuo

This figure shows the co-authorship network connecting the top 25 collaborators of Xialin Zuo. A scholar is included among the top collaborators of Xialin Zuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xialin Zuo. Xialin Zuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Dan C., Xialin Zuo, Lixuan Zhan, et al.. (2024). The p75 neurotrophin receptor attenuates secondary thalamic damage after cortical infarction by promoting angiogenesis. CNS Neuroscience & Therapeutics. 30(7). e14875–e14875. 1 indexed citations
2.
Qi, Xing, Xialin Zuo, Wenhao Huang, et al.. (2023). Transplantation of hESCs-Derived Neural Progenitor Cells Alleviates Secondary Damage of Thalamus After Focal Cerebral Infarction in Rats. Stem Cells Translational Medicine. 12(8). 553–568. 3 indexed citations
3.
Shi, Zhe, Lixuan Zhan, Weiwen Sun, et al.. (2021). Neuroprotective Effects of Rhodiola Sacra on Transient Global Cerebral Ischemia Through Activating AMPK/Nrf2 Pathway in Rats. Antioxidants and Redox Signaling. 36(7-9). 567–591. 12 indexed citations
4.
Zuo, Xialin, Shengquan Hu, Yanyan Tang, et al.. (2019). Attenuation of secondary damage and Aβ deposits in the ipsilateral thalamus of dMCAO rats through reduction of cathepsin B by bis(propyl)-cognitin, a multifunctional dimer. Neuropharmacology. 162. 107786–107786. 9 indexed citations
5.
Tang, Yanyan, et al.. (2019). Bone Marrow Stromal Cells Alleviate Secondary Damage in the Substantia Nigra After Focal Cerebral Infarction in Rats. Frontiers in Cellular Neuroscience. 13. 338–338. 6 indexed citations
7.
Zuo, Xialin, Qinghua Hou, Xiaohong Chen, et al.. (2018). Inhibition of Cathepsins B Induces Neuroprotection Against Secondary Degeneration in Ipsilateral Substantia Nigra After Focal Cortical Infarction in Adult Male Rats. Frontiers in Aging Neuroscience. 10. 125–125. 18 indexed citations
8.
Wu, Zhuomin, Ping Wu, Xialin Zuo, et al.. (2016). LncRNA-N1LR Enhances Neuroprotection Against Ischemic Stroke Probably by Inhibiting p53 Phosphorylation. Molecular Neurobiology. 54(10). 7670–7685. 115 indexed citations
9.
Zuo, Xialin, et al.. (2016). Inhibition of Cathepsin B Alleviates Secondary Degeneration in Ipsilateral Thalamus After Focal Cerebral Infarction in Adult Rats. Journal of Neuropathology & Experimental Neurology. 75(9). 816–826. 17 indexed citations
10.
Zuo, Xialin, Houliang Deng, Ping Wu, & En Xu. (2015). Do different reperfusion methods affect the outcomes of stroke induced by MCAO in adult rats?. International Journal of Neuroscience. 126(9). 850–855. 5 indexed citations
11.
Deng, Houliang, Xialin Zuo, Jingjing Zhang, et al.. (2015). α-lipoic acid protects against cerebral ischemia/reperfusion-induced injury in rats. Molecular Medicine Reports. 11(5). 3659–3665. 29 indexed citations
12.
Zhang, Jingjing, Houliang Deng, Li Liu, et al.. (2015). α-lipoic acid protects against hypoxia/reoxygenation-induced injury in human umbilical vein endothelial cells through suppression of apoptosis and autophagy. Molecular Medicine Reports. 12(1). 180–186. 12 indexed citations
13.
Liu, Xiaoxia, Wei Wang, Dmitry Samarsky, et al.. (2014). Tumor-targeted in vivo gene silencing via systemic delivery of cRGD-conjugated siRNA. Nucleic Acids Research. 42(18). 11805–11817. 64 indexed citations
14.
Ji, Aimin, Xiaoxia Liu, Qian Xu, et al.. (2014). Self-assembled nanoparticles based on the c(RGDfk) peptide for the delivery of siRNA targeting the VEGFR2 gene for tumor therapy. International Journal of Nanomedicine. 9. 3509–3509. 21 indexed citations
15.
Wu, Ping, Xialin Zuo, Houliang Deng, et al.. (2013). Roles of long noncoding RNAs in brain development, functional diversification and neurodegenerative diseases. Brain Research Bulletin. 97. 69–80. 296 indexed citations
16.
Xu, Qian, Jianhong Pan, Jingwen Yu, et al.. (2013). Meta-analysis of methylcobalamin alone and in combination with lipoic acid in patients with diabetic peripheral neuropathy. Diabetes Research and Clinical Practice. 101(2). 99–105. 45 indexed citations
17.
Wu, Ping, Xialin Zuo, & Aimin Ji. (2012). Stroke-induced microRNAs: The potential therapeutic role for stroke. Experimental and Therapeutic Medicine. 3(4). 571–576. 36 indexed citations
18.
Zuo, Xialin, Ping Wu, & Aimin Ji. (2012). Nylon filament coated with paraffin for intraluminal permanent middle cerebral artery occlusion in rats. Neuroscience Letters. 519(1). 42–46. 17 indexed citations
19.
Chen, Shan, Xiaoxia Liu, Xialin Zuo, et al.. (2012). Combination therapy with VEGFR2 and EGFR siRNA enhances the antitumor effect of cisplatin in non-small cell lung cancer xenografts. Oncology Reports. 29(1). 260–268. 21 indexed citations
20.
Liu, Xiaoxia, Li Liu, Qian Xu, et al.. (2012). MicroRNA as a novel drug target for cancer therapy. Expert Opinion on Biological Therapy. 12(5). 573–580. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026